Unveiling metabolome heterogeneity in three species from Coccoloba and Ruprechtia through multiple approaches of UPLC/HRMS and chemometric analysis in relation to antidiabetic, antioxidant and antiglycation activities
Fatma Abdelhakim Mohamed, Mohamed A. Salem, Mohammed N. A. Khalil, Ali M. El-Halawany, Amira S. El Senousy
{"title":"Unveiling metabolome heterogeneity in three species from Coccoloba and Ruprechtia through multiple approaches of UPLC/HRMS and chemometric analysis in relation to antidiabetic, antioxidant and antiglycation activities","authors":"Fatma Abdelhakim Mohamed, Mohamed A. Salem, Mohammed N. A. Khalil, Ali M. El-Halawany, Amira S. El Senousy","doi":"10.1186/s43094-025-00787-6","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Diabetes mellitus (DM) is a major intricate metabolic disorder, being one of the chief causes of mortality worldwide. <i>Coccoloba</i> and <i>Ruprechtia</i> are two of the most intriguing polyphenol-rich genera within the Polygonaceae family. The potential of <i>Coccoloba uvifera, Coccoloba peltata</i> and <i>Ruprechtia salicifolia</i> total extracts and fractions as antioxidant, antidiabetic and anti-glycating agents was evaluated and correlated with their chemical composition via multiple approaches of metabolic profiling.</p><h3>Results</h3><p>All the total ethanolic extracts of plant leaves revealed remarkable antioxidant activities in terms of scavenging DPPH and ABTS radicals, as well as ferric reducing antioxidant power (FRAP). Despite having more or less comparable total phenolic and flavonoid contents, <i>C. uvifera</i> extract showed the highest inhibitory activity against <i>α</i>-glucosidase enzyme (IC<sub>50</sub> 7.985 ± 1.08 μg/mL), being more potent than acarbose (20-fold). All total extracts demonstrated moderately high anti-AGEs (> 63% inhibition) in BSA-fructose model. Among all examined fractions, <i>C. uvifera</i> 50% MeOH fraction exhibited the most potent antioxidant activity in DPPH, ABTS and FRAP assays (5697.33 ± 360.7, 3078.9 ± 249, 1664.02 ± 220 µM ascorbic acid equivalent/mg extract, respectively) and the highest <i>α</i>-glucosidase inhibitory activity (IC<sub>50</sub> 3.36 ± 1.04 μg/mL). A total of 140 compounds, belonging to different classes, were annotated in the three species via UPLC-HRMS, where flavonoids and phenolic acids represented the major classes. Multivariate and correlation analyses revealed the key phytochemicals contributing to <i>α</i>-glucosidase inhibition as 1-<i>O</i>-vanilloyl-hexoside, 1,3-<i>O</i>-diferuloylglycerol, drovomifoliol-<i>O</i>-glucopyranoside, protocatechuic acid glucoside, digalloyl glucose and coumaric acid sulphate.</p><h3>Conclusion</h3><p><i>C. uvifera</i> leaves extract and its 50% MeOH fraction had a superb potential to alleviate DM and its complications through their antioxidant, antiglycation and <i>α</i>-glucosidase inhibitory activities mediated by their versatile polyphenolic phytochemicals.</p><h3>Graphical abstract</h3><div><figure><div><div><picture><source><img></source></picture></div></div></figure></div></div>","PeriodicalId":577,"journal":{"name":"Future Journal of Pharmaceutical Sciences","volume":"11 1","pages":""},"PeriodicalIF":3.4000,"publicationDate":"2025-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://fjps.springeropen.com/counter/pdf/10.1186/s43094-025-00787-6","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Future Journal of Pharmaceutical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://link.springer.com/article/10.1186/s43094-025-00787-6","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Diabetes mellitus (DM) is a major intricate metabolic disorder, being one of the chief causes of mortality worldwide. Coccoloba and Ruprechtia are two of the most intriguing polyphenol-rich genera within the Polygonaceae family. The potential of Coccoloba uvifera, Coccoloba peltata and Ruprechtia salicifolia total extracts and fractions as antioxidant, antidiabetic and anti-glycating agents was evaluated and correlated with their chemical composition via multiple approaches of metabolic profiling.
Results
All the total ethanolic extracts of plant leaves revealed remarkable antioxidant activities in terms of scavenging DPPH and ABTS radicals, as well as ferric reducing antioxidant power (FRAP). Despite having more or less comparable total phenolic and flavonoid contents, C. uvifera extract showed the highest inhibitory activity against α-glucosidase enzyme (IC50 7.985 ± 1.08 μg/mL), being more potent than acarbose (20-fold). All total extracts demonstrated moderately high anti-AGEs (> 63% inhibition) in BSA-fructose model. Among all examined fractions, C. uvifera 50% MeOH fraction exhibited the most potent antioxidant activity in DPPH, ABTS and FRAP assays (5697.33 ± 360.7, 3078.9 ± 249, 1664.02 ± 220 µM ascorbic acid equivalent/mg extract, respectively) and the highest α-glucosidase inhibitory activity (IC50 3.36 ± 1.04 μg/mL). A total of 140 compounds, belonging to different classes, were annotated in the three species via UPLC-HRMS, where flavonoids and phenolic acids represented the major classes. Multivariate and correlation analyses revealed the key phytochemicals contributing to α-glucosidase inhibition as 1-O-vanilloyl-hexoside, 1,3-O-diferuloylglycerol, drovomifoliol-O-glucopyranoside, protocatechuic acid glucoside, digalloyl glucose and coumaric acid sulphate.
Conclusion
C. uvifera leaves extract and its 50% MeOH fraction had a superb potential to alleviate DM and its complications through their antioxidant, antiglycation and α-glucosidase inhibitory activities mediated by their versatile polyphenolic phytochemicals.
期刊介绍:
Future Journal of Pharmaceutical Sciences (FJPS) is the official journal of the Future University in Egypt. It is a peer-reviewed, open access journal which publishes original research articles, review articles and case studies on all aspects of pharmaceutical sciences and technologies, pharmacy practice and related clinical aspects, and pharmacy education. The journal publishes articles covering developments in drug absorption and metabolism, pharmacokinetics and dynamics, drug delivery systems, drug targeting and nano-technology. It also covers development of new systems, methods and techniques in pharmacy education and practice. The scope of the journal also extends to cover advancements in toxicology, cell and molecular biology, biomedical research, clinical and pharmaceutical microbiology, pharmaceutical biotechnology, medicinal chemistry, phytochemistry and nutraceuticals.